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INTRODUCTION
Blood can transport essential substances to different tissues in 
the body. Serum analytes may change in some situations and 
conditions [1,2]. Blood donors must be in good health to save 
the life of blood recipient who have lost blood. Measures of liver 
enzymes may help to increase safety of blood donation for both 
blood donor and recipient. The important liver enzymes are a 
group of enzymes that include Alanine Aminotransferase (ALT), 
Aspartate Aminotransferase (AST) Gamma γ-Glutamyltransferase 
(GGT) [3]. Aminotransferases are a group of enzymes that 
catalyze the reversible transfer of the amino group, from an 
α-amino acid to an oxo-acid [4]. There is a significant tendency 
to investigate variations of liver enzyme activities as biomarkers 
in healthy subjects and people with disease. The determination 
of serum levels of liver enzymes can be practical to assess liver 
function in different condition [5]. In general, liver enzymes are 
most increased in subjects with liver disease this may reflect 
liver damage. The increase level of aspartate aminotransferase, 
alanine aminotransferase, γ-glutamyltransferase as liver enzymes 
varies in different studies [6]. Recent studies showed that 
there are associations between increased levels of aspartate 
aminotransferase, alanine aminotransferase and the development 
of diabetes, metabolic syndrome, and overall mortality [7-11]. 
Several studies have indicated that changes in serum AST, ALT 
or GGT levels is associated with risk of cardiovascular disease, 
type 2 diabetes, stroke, or hypertension occurrence [12,13]. 
It has been reported that variations in liver enzymes levels have 
also taken into account as diagnostic parameters in a variety of 
extra-hepatic conditions [13]. The levels of liver transaminases in 
serum are useful biomarkers of liver injury in a patient with some 
degree of intact liver function that must be detected early [14]. In 
medical studies, there are different definitions of normal ranges 
and different interpretation of data for liver enzymes. The aim of 
this study was to determine serum γ-glutamyltransferase, alanine 
 
 
aminotransferase, and aspartate aminotransferase activities in 
apparently healthy blood donors in Gorgan Blood Transfusion 
Center, Iran. We have analysed these data to examine whether the 
liver enzymes activities are influenced by ethnicity, familial history 
of liver disease and diabetes, smoking habit in the healthy blood 
donors. Data extracted from such studies could be very valuable 
in modern medicine and future prospect in drug designing. 
MATERIALS AND METHODS
Clinical and Laboratory Assessment
This cross- sectional study was done from May 2015 to February 
2016. Four hundred fifty healthy males were selected from three 
different ethnic groups, who attended to Gorgan Blood Transfusion 
Center (Golestan province, South East of Caspian Sea) for blood 
donation. A standard interview and biochemical analysis were 
conducted for each participant. The study groups consisted of 
150 healthy males from each three ethnicity groups. 
The ethnicity was defined as follows: 1) Fars ethnic group: residing 
in this region since long time and are considered to be the native 
resident of this region. Their native language is Farsi; 2) Sistanee 
ethnic group: people immigrated to this region from Sistan and 
Baluchistan Province during past decades. Their native language 
is Sistanee; 3) Turkman ethnic group: this group does not have 
family relation with other ethnic group, therefore can be considered 
as an independent race and are residing in a particular rural area. 
Their native language is Turkman. 
Samples were tested according to the recog nized screening test 
algorithms for hepatitis B surface antigen, anti-HCV, anti-HIV1/2, 
syphilis and for AST, ALT and GGT levels. Personal and family 
history of diabetes mellitus, chronic liver disease according to 
diagnosis of physician, cigarette smoking habit, medication history 
and demographic findings such as body weight, height, body mass 
index and blood pressure were recorded. Weight and height were 
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ABSTRACT
Introduction: Measure of liver enzymes may help to increase 
safety of blood donation for both blood donor and recipient. 
Determination of liver enzymes may prepare valuable clinical 
information. 
Aim: To assess serum γ-Glutamyltransferase (GGT), Alanine Amino-
transferase (ALT), and Aspartate Aminotransferase (AST) activities 
in healthy blood donors in different ethnic groups in Gorgan.
Materials and Methods: This study was performed in 450 
healthy male blood donors, in three ethnic groups (Fars, 
Sistanee and Turkman) who attended Gorgan blood transfusion 
center. Liver enzymes (GGT, ALT and AST) were determined.
Results: Serum AST and ALT in three ethnic groups were significant 
except for serum GGT levels. There was significant correlation 
between family histories of liver disease and systolic blood 
pressure and AST in Fars, and GGT in Sistanee ethnic groups.
Conclusion: Several factors, such as age, family history of 
diabetes mellitus, family history of liver disease and smoking 
habit had no effect on some liver enzymes in different ethnic 
groups in this area. Variation of AST, ALT, and GGT enzyme 
activities in healthy subjects was associated with some subjects 
in our study groups. According to our study, it suggests that 
screening of AST and GGT enzymes in subjects with family 
history of liver disease is necessary in different ethnic groups.
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measured using digital scale and tape meter. Calculation of Body 
Mass Index (BMI) was calculated by dividing weight in kilograms 
by height in meters squared. Overweight and obese were specified 
as BMI = 25.0-29.9 and ≥30 Kg/m2, respectively [15]. Systolic 
and diastolic blood pressure measurement was done by using 
a standard mercury manometer with different subjects in sitting 
position, from their right hands. Biochemical parameters were 
carried out for each participant. Serum AST, ALT and GGT, levels 
were measured using commercial kits and spectrophotometer 
technique in the Metabolic Disorders Research Center, Gorgan 
Faculty of Medicine. 
The study protocol was approved by Ethical committees of the 
Research Deputy of Golestan University of Medical Sciences and 
a written informed consent was obtained from each participant. 
STATISTICAL ANALySIS
Analysis of data was done using SPSS software version 16.0 
(SPSS Inc., Chicago, IL, USA). The results were shown as mean 
± SD. One-way analysis of variance (ANOVA) was used to test 
the variable differences between ethnic groups. For analysing 
statistical association among categorical variables (family history 
of diabetes mellitus, family history of liver disease and smoking 
habit) in relation to Systolic Blood Pressure (SBP), Diastolic Blood 
Pressure (DBP), AST, ALT, and GGT levels, Pearson’s correlation 
test were done. The p-values <0.05 were considered statistically 
significant.
RESULTS
The mean age of 450 participants was 36.22±10.45 (range of 
18 to 95 years). The mean body mass index of most participants 
was 28.20± 3.98 (Kg/m2). The characteristics of the study ethnic 
groups in relation to serum GGT, AST, ALT, Age, BMI, systolic and 
diastolic blood pressures, are shown in [Table/Fig-1]. 
Tests for differences in characteristics across the three ethnic 
groups were significant except for serum GGT levels. Correlation 
between family history of diabetes mellitus, family history of liver 
disease and smoking habit with age, body mass index, and serum 
Alanine Aminotransferase, Aspartate Aminotransferase, gamma 
γ-glutamyltransferase and systolic and diastolic blood pressure 
in different ethnic groups are shown in [Table/Fig-2-4]. Spearman 
correlation analysis showed that there were there was significant 
correlation between family histories of liver disease and SBP and 
AST in Fars and GGT in Sistanee ethnic groups.
DISCUSSION
Recent studies have shown that there are genetic differences 
between subjects to expression of RNA, translation and protein 
levels. The genetic variations in different ethnic groups may be 
important information for drug designing prospects in the future 
[7]. There is a greater ethnic variation in the incidences of many 
diseases [12]. 
Several studies have indicated that serum GGT is associated 
with risk of death or development of cardiovascular disease, 
type 2 diabetes, stroke, or hypertension. Study in Tehran blood 
transfusion center on male blood donors have revealed significant 
associations between increased in AST, ALT, or GGT activities 
and body mass index. AST, ALT, and GGT levels had positive 
correlation with family history of liver disease [16]. 
Study by Whitfield et al., exhibited the importance of genetic and 
environmental sources of variation in GGT. They have shown 
significant correlation between GGT and body mass index and 
blood pressure. They concluded that these correlation were more 
attributable to genes that affect GGT and cardiovascular risk 
factors than to environmental factors [12]. 
The results of this study indicated that serum GGT and AST, 
and SBP are associated with ethnicity and significant correlation 
Variables Fars 
(n=150)
Turkman 
(n=150)
Sistanee 
(n=150)
p-value
Age (years) 36.48±11.56 36.02±10.42 36.16±9.32 0.856
Systolic blood pressure 
(mm Hg)
120.34±12.47 117.2±12.65 116.36±10.39 0.007
Diastolic blood pressure 
(mm Hg)
78.41±9.83 73.45±8.01 72.90±7.88 0.01
Body mass index (Kg/m2) 28.37±4.46 28.66±4.33 27.57±4.29 0.687
Alanine Aminotransferase 
(IU/L)
16.92±15.32 27.68±24.56 26.126±21.04 <0.001
Aspartate 
Aminotransferase (IU/L)
23.17±16.46 32.16±31.69 30.77±24.02 0.002
gamma 
γ-glutamyltransferase 
(IU/L)
32.56±24.37 30.38±34.29 29.65±30.39 0.060
[Table/Fig-1]: Characteristics of study population according to their ethnic groups.
Variables
Family history of 
liver disease
Family history of 
diabetes Smoking habits
r p-value r p-value r p-value
Age -0.036 0.661 0.020 0.811 0.035 0.667
BMI -0.002 0.981 -0.113 0170 0.082 0.320
SBP -2.103 0.035 -0.739 0.46 -0.698 0.485
DBP -1.814 0.070 -0.975 0.330 -1.107 0.268
ALT -2.624 0.059 -0.998 0.306 -1.376 0.169
AST -0.590 0.009 -0.395 0.318 -0.498 0.618
GGT -1.885 0.555 -1.023 0.693 -1.409 0.159
[Table/Fig-2]: Parameters correlated with Age, BMI and serum ALT (Alanine 
Aminotransferase), Aspartate Aminotransferase, GGT (gamma γ-glutamyltransferase) 
and SBP and DBP (systolic and diastolic blood pressure) of Fars ethnic group.
Variables
Family history of 
liver disease
Family history of 
diabetes Smoking habits
r p-value r p-value r p-value
Age 0.033 0.692 0.113 0.168 0.033 0.692
BMI -0.011 0.891 0.001 0.991 -0.021 0.799
SBP -0.630 0.529 -1.293 0.196 -0.451 0.652
DBP -1.238 0.216 -0.057 0.955 -0.025 0.980
ALT -1.154 0.248 -0.381 0.703 -1.362 0.173
AST -0.400 0.689 -0.832 0.406 -1.601 0.109
GGT -0.469 0.639 -0.060 0.953 -1.880 0.060
[Table/Fig-3]: Parameters correlated with Age, BMI and serum ALT (Alanine 
Aminotransferase), Aspartate Aminotransferase, GGT (gamma γ-glutamyltransferase) 
and SBP and DBP (systolic and diastolic blood pressure) of Turkman ethnic group.
Variables
Family history of 
liver disease
Family history of 
diabetes Smoking habits
r p-value r p-value r p-value
Age 0.042 0.608 0.099 0.226 -0.098 0.232
BMI -0.054 0.515 -0.0187 0.222 0.117 0.153
SBP -0.238 0.812 -0.838 0.402 -0.067 0.947
DBP -0.582 0.560 -0.528 0.598 -0.168 0.867
ALT -0.343 0.732 -0.035 0.972 -0.048 0.962
AST -0.230 0.818 -1.152 0.249 -0.955 0.340
GGT -2.537 0.011 -1.633 0.103 -0.095 0.924
[Table/Fig-4]: Parameters correlated with Age, BMI and serum ALT (Alanine Amino-
transferase), Aspartate Aminotransferase, GGT (gamma γ-glutamyltransferase) and 
SBP and DBP (systolic and diastolic blood pressure) of Sistanee ethnic group.
between family history of liver disease and liver enzymes may be 
attributable to genes that affect AST in Fars and GGT in Sistanee 
populations. 
Study of Khedmat et al., also revealed the association of liver 
enzymes and body mass index, age and body weight [17]. Study 
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of Mohammadnejad et al., showed that serum ALT activity was 
associated with body mass index and male gender, but not with 
age [16]. Our study was in line with finding of Mohammadnejad et 
al., [16] while our results were not consistent with other studies 
[18-20]. 
A study showed a correlation between BMI and liver enzymes. It 
was reported that increase in BMI cause significant increase in liver 
enzymes in males [15]. Many other studies have shown that there 
is an association between increased serum activity of various liver 
enzymes with overweight or obesity, especially ALT and AST [21-
23] which is not in agreement with our study (Data is not shown). 
The findings of our study are in agreement with other findings which 
showed a significant correlation between the activities of AST, ALT, 
and GGT levels, systolic blood pressure and family history of liver 
disease in healthy blood donors [17,18]. In our study, correlation 
between family history of liver disease and elevated liver enzymes 
can be attributed to genes that may affect AST, ALT and GGT levels. 
Abnormal liver enzymes may be present without symptoms and 
signs of liver disease. Liver enzymes may associate with variations 
of some biochemical factors. Nakanishi et al., showed the 
association between serum GGT and risk of metabolic syndrome 
and type 2 diabetes mellitus. They have revealed that serum GGT 
may be an important predictor for developing different diseases 
such as metabolic syndrome and type 2 diabetes mellitus [13]. Kim 
et al., showed that the serum ALT and GGT levels were significantly 
associated with metabolic syndrome in only male subjects [18]. 
LIMITATION
There were some limitations in our study. All participants in our 
study were male. Thus we could not compare the liver enzyme 
variation in male and female blood donors. We did not consider 
the physical activity and eating habits. 
CONCLUSION
Several factors, such as age, family history of diabetes mellitus, 
family history of liver disease and smoking habit had no effect on 
some liver enzymes in different ethnic groups in this area. Variation 
of AST, ALT, and GGT enzyme activities in healthy subjects were 
associated with some subjects in our study groups. According to 
our study, it suggests that screening of AST and GGT enzymes in 
subjects with family history of liver disease is necessary.
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